Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Search results

Showing results for

New study improves early detection of life-threatening infection in children across South and South East Asia

A new study published in Nature Medicine suggests that simple, low-cost tools could help health workers identify children at risk of life-threatening infection earlier, improving access to urgent care in across South and South East Asia.

New rabies vaccine could provide protection for adults and children with a single dose

A new clinical trial led by researchers at the Jenner Institute in collaboration Ifakara Health Institute Tanzania, suggests that a single-dose rabies vaccine could provide safe, long-lasting protection in both adults and children. The research could lead to a simpler, lower-cost approach that could transform rabies prevention in high-risk regions.

Expert Comment: World Malaria Day 2026 - Malaria vs the Data Collective

Malaria is one of the world’s oldest known diseases, but it is a modern disease too - it continues to kill roughly 600,000 people each year. Most of these people are children, living in Sub-Saharan Africa.

University of Oxford and Serum Institute of India agree licence to advance the next-generation multi-stage malaria vaccine candidate component

The University of Oxford, through Oxford University Innovation (OUI), and the Serum Institute of India (SII), a Cyrus Poonawalla group company and the world’s largest vaccine manufacturer by volume, have entered into a licence agreement to support the development and manufacture of the new malaria vaccine candidate R78C, based on two Plasmodium falciparum blood-stage antigens (RIPR and CyPRA), for use in clinical settings.

From Kilifi to the World: Rethinking Malaria Control Through Three Decades of Research

Since 1995, the KEMRI–Wellcome Trust Research Programme has quietly reshaped the global fight against malaria, not through a single breakthrough, but through a sustained commitment to evidence, context and people. Its work offers a powerful lesson: defeating malaria is not just about tools, but about understanding systems, adapting strategies and investing in local science. This is a thought leadership piece by Professor Isabella Oyier, Head of Bioscience, KEMRI-Wellcome

Innovative housing design cools homes, saves lives in Africa

New housing designs that reduce indoor temperatures and improve ventilation can help cut infectious disease and improve health outcomes in sub-Saharan Africa, according to new Oxford-led research.

Reimagining community mental health in Kenya through the 'Nyumba Kumi' model

Community-based approaches like the Nyumba Kumi model highlight how locally embedded partnerships can address mental health challenges in low-resource settings.

Collaboration with the Nepal Public Health Foundation explores maternal health and epilepsy

A new study, co-led by Professor Arjune Sen and supported by Nuffield Department of Clinical Neurosciences, aims to improve understanding of the risk factors, care pathways and broader health and social impacts of epilepsy in Nepal.

Blood test may improve survival of childhood cancer in Africa

A simple blood test could speed up diagnosis and improve outcomes for children with Africa’s most common childhood cancer.

Oxford and Serum Institute of India sign IP license agreement to advance NipahB vaccine candidate

The University of Oxford and Serum Institute of India Pvt. Ltd. (SII), a Cyrus Poonawalla Group company and the world’s largest vaccine manufacturer, have signed an Intellectual Property license agreement to advance the development and manufacture of the ChAdOx1 NipahB vaccine candidate. Professor Brian Angus is Chief Investigator of the trial.

Oxford research highlights the global challenge of iron deficiency

Iron deficiency affects more than a billion people worldwide and remains a leading cause of anaemia. Oxford researchers are uncovering how iron levels shape immunity and infection - insights that could inform safer, more effective strategies to tackle iron deficiency globally.

Tackling the global hypertension crisis

The global hypertension crisis reflects not a lack of evidence, but a lack of implementation.

Oxford joins new West Africa consortium to accelerate climate and health solutions

Researchers from the University of Oxford have joined African universities and regional experts who are working with Wellcome to establish new science and policy consortiums that will address the escalating public health crisis driven by climate change - saving lives and livelihoods.

Reimagining primary health care: a historical and contemporary scoping review of community-based primary health care models and innovations

How can community-based primary health care adapt to rapid demographic change, rising chronic disease and digital transformation?

Blood test predicts risk of death in acutely ill children in lower-income countries

An international study has identified a blood-based indicator of intestinal damage and inflammation that strongly predicts mortality in sick children. The new biomarker could help to identify those children at greatest risk of dying after hospitalisation in parts of the world with limited resources.

‘Creeping catastrophe’: Climate change is driving global rise in infectious diseases, leading health experts warn

Infectious diseases such as malaria, dengue, and tuberculosis are considered to pose as great a challenge to global health as new or emerging pathogens, according to a major international study led by The Global Health Network at Oxford’s Nuffield Department of Medicine and commissioned by Wellcome.

New analysis highlights urgent need to close global gaps in genomic surveillance of antimicrobial resistance

A major new study led by the University of Oxford and global partners has exposed significant global blind spots in genomic surveillance of antimicrobial resistance (AMR), warning that large parts of the world lack the data needed to track and respond to emerging threats.

Innovative Oxford child anxiety treatment to be rolled out internationally

An effective online treatment for childhood anxiety developed by a team at the University of Oxford is to be adapted and tested in five countries in Asia and South America, with the aim of driving widespread implementation in the future.

Oxford research tackles global inequities in access to medicines

A new Oxford Martin School programme is addressing one of global health’s most urgent and overlooked challenges: ensuring equitable access to essential medicines in low- and middle-income countries (LMICs).

Oxford Global Health partners with Oxford Martin School on Climate and Child Health

Oxford Global Health has partnered with the Oxford Martin School to examine how the climate crisis is shaping children’s health and wellbeing across Africa.

Load More